Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Doudet, Doris J.
Aigner, Thomas G.
McLellan, Catherine A.
and
Cohen, Robert M.
1992.
Positron emission tomography with 18F-DOPA: Interpretation and biological correlates in nonhuman primates.
Psychiatry Research: Neuroimaging,
Vol. 45,
Issue. 3,
p.
153.
Otsuka, Makoto
Ichiya, Yuichi
Shima, Fumio
Kuwabara, Yasuo
Sasaki, Masayuki
Fukumura, Toshimitsu
Kato, Motohiro
Masuda, Kouji
and
Goto, Ikuo
1992.
Increased striatal 18F-Dopa uptake and normal glucose metabolism in idiopathic dystonia syndrome.
Journal of the Neurological Sciences,
Vol. 111,
Issue. 2,
p.
195.
Lang, Anthony E.
Curran, Terry
Provias, John
and
Bergeron, Catherine
1994.
Striatonigral Degeneration: Iron Deposition in Putamen Correlates with the Slit-like Void Signal of Magnetic Resonance Imaging.
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques,
Vol. 21,
Issue. 4,
p.
311.
Curran, Terry
and
Lang, Anthony E.
1994.
Parkinsonian syndromes associated with hydrocephalus: Case reports, a review of the literature, and pathophysiological hypotheses.
Movement Disorders,
Vol. 9,
Issue. 5,
p.
508.
Holthoff, V. A.
Vieregge, P.
Kessler, J.
Pietrzyk, U.
Herholz, K.
Bönner, J.
Wagner, R.
Wienhard, K.
Pawlik, G.
and
Heiss, W.‐D.
1994.
Discordant twins with Parkinson's disease: Positron emission tomography and early signs of impaired cognitive circuits.
Annals of Neurology,
Vol. 36,
Issue. 2,
p.
176.
Ivy Carroll, F.
Scheffel, U.
Dannals, Robert F.
Boja, John W.
and
Kuhar, Michael J.
1995.
Development of imaging agents for the dopamine transporter.
Medicinal Research Reviews,
Vol. 15,
Issue. 5,
p.
419.
Lang, Anthony E.
1995.
Hemiatrophy, juvenile‐onset exertional alternating leg paresis, hypotonia, and hemidystonia and adult‐onset hemiparkinsonism: The spectrum of hemiparkinsonism‐hemiatrophy syndrome.
Movement Disorders,
Vol. 10,
Issue. 4,
p.
489.
Firnau, Günter
Chirakal, Raman
Wahl, Lindi
Chen, Jia Juen
Murthy, Dilip
Nahmias, Claude
and
Garnett, E. Stephen
1995.
Chemists’ Views of Imaging Centers.
p.
237.
Nahmias, Claude
Wahl, Lindi
Chirakal, Raman
Firnau, Gunter
and
Garnett, E. Stephen
1995.
A probe for intracerebral aromatic amino‐acid decarboxylase activity: Distribution and kinetics of [18F]6‐fluoro‐L‐m‐tyrosine in the human brain.
Movement Disorders,
Vol. 10,
Issue. 3,
p.
298.
Otsuka, Makoto
Ichiya, Yuichi
Kuwabara, Yasuo
Hosokawa, Shinichi
Sasaki, Masayuki
Yoshida, Tsuyoshi
Fukumura, Toshimitsu
Masuda, Kouji
and
Kato, Motohiro
1996.
Differences in the reduced 18F-Dopa uptakes of the caudate and the putamen in Parkinson's disease: correlations with the three main symptoms.
Journal of the Neurological Sciences,
Vol. 136,
Issue. 1-2,
p.
169.
Deep, Paul
Kuwabara, Hiroto
Gjedde, Albert
and
Cumming, Paul
1997.
The kinetic behaviour of [3H]DOPA in living rat brain investigated by compartmental modelling of static autoradiograms.
Journal of Neuroscience Methods,
Vol. 78,
Issue. 1-2,
p.
157.
Otsuka, Makoto
Kuwabara, Yasuo
Ichiya, Yuichi
Hosokawa, Sinichi
Sasaki, Masayuki
Yoshida, Tsuyoshi
Fukumura, Toshimitsu
Kato, Motohiro
and
Masuda, Kouji
1997.
Differentiating between multiple system atrophy and Parkinson’s disease by positron emission tomography with18F-dopa and18F-FDG.
Annals of Nuclear Medicine,
Vol. 11,
Issue. 3,
p.
251.
Chirakal, Raman
Vasdev, Neil
Schrobilgen, Gary J.
and
Nahmias, Claude
1999.
Radiochemical and NMR spectroscopic investigation of the solvent effect on the electrophilic elemental fluorination of L-DOPA: synthesis of []5-fluoro-L-DOPA.
Journal of Fluorine Chemistry,
Vol. 99,
Issue. 1,
p.
87.
Chirakal, R.
Vasdev, N.
Schrobilgen, G. J.
Amano, S.
and
Nahmias, C.
2001.
A comparative study of the in vivo behaviour of [18F] 2‐, 5‐ and 6‐fluoro‐L‐dopa in the human brain.
Journal of Labelled Compounds and Radiopharmaceuticals,
Vol. 44,
Issue. S1,
Ito, Kengo
Nagano‐Saito, Atsuko
Kato, Takashi
Arahata, Yutaka
Nakamura, Akinori
Kawasumi, Yasuhiro
Hatano, Kentaro
Abe, Yuji
Yamada, Takako
Kachi, Teruhiko
and
Brooks, David J.
2002.
Striatal and extrastriatal dysfunction in Parkinson’s disease with dementia: a 6‐[18F]fluoro‐l‐dopa PET study.
Brain,
Vol. 125,
Issue. 6,
p.
1358.
Chirakal, Raman
Vasdev, Neil
Asselin, Marie-Claude
Schrobilgen, Gary J
and
Nahmias, Claude
2002.
The effect of aromatic fluorine substitution in l-DOPA on the in vivo behaviour of []2-, []5- and []6-fluoro-l-DOPA in the human brain.
Journal of Fluorine Chemistry,
Vol. 115,
Issue. 1,
p.
33.
Quik, M.
Bordia, T.
Forno, L.
and
McIntosh, J. M.
2004.
Loss of α‐conotoxinMII‐ and A85380‐sensitive nicotinic receptors in Parkinson's disease striatum.
Journal of Neurochemistry,
Vol. 88,
Issue. 3,
p.
668.
Nandhagopal, R.
Kuramoto, L.
Schulzer, M.
Mak, E.
Cragg, J.
Lee, C. S.
McKenzie, J.
McCormick, S.
Samii, A.
Troiano, A.
Ruth, T. J.
Sossi, V.
de la Fuente-Fernandez, R.
Calne, D. B.
and
Stoessl, A. J.
2009.
Longitudinal progression of sporadic Parkinson's disease: a multi-tracer positron emission tomography study.
Brain,
Vol. 132,
Issue. 11,
p.
2970.
Miletich, Robert S.
2009.
Positron Emission Tomography for Neurologists.
Neurologic Clinics,
Vol. 27,
Issue. 1,
p.
61.
Ballanger, B.
van Eimeren, T.
and
Strafella, A. P.
2009.
Textbook of Stereotactic and Functional Neurosurgery.
p.
307.